Vaginitis is one of the most common gynecologic problems seen in ambulatory practice. Join us in discussing the differential diagnosis, which includes not only a vaginal infection, but also cervicitis, a physiologic discharge, atrophic vaginitis, and iatrogenic vaginitis. A precise diagnosis can be achieved with a careful history, focused examination, and skilled use of the office laboratory. This talk will pave the way to an accurate diagnosis, after which, effective therapy can be prescribed.
Learn how to prescribe the correct contraceptive to a patient after assessing their previous medical history. In this activity, Dr. Batur reviews the available contraception methods including the newest options on the market. This activity also discusses practice recommendations for contraceptive use along with safety concerns associated with each class of contraceptives.
This session will present an overview of the common causes of chronic pelvic pain. The link between chronic pelvic pain and sexual dysfunction will be discussed. A classification of female sexual dysfunction will be presented and participants will leave with an approach to female patients who present with sexual dysfunction.
Managing depression during pregnancy and lactation is a complex clinical task encompassing the two concomitant medical conditions (i.e., pregnancy and psychiatric illness) and the welfare of two patients (i.e., mother and child). Minimizing infant exposure to the potential risks of both maternal depression and psychotropic medication is the preeminent clinical objective. The audience will learn the relative risks of maternal depression, antidepressant medications during pregnancy, and postpartum/lactation. A treatment model will be introduced to maximize mother and infant well-being when depression arises during pregnancy and the postpartum period.
Dr. Crandall answers some frequently asked questions about osteoporosis diagnosis and treatment. She discusses the pros and cons of different diagnostic tests for osteoporosis and speaks on certain controversies regarding bone density monitoring and combination therapy.
Patients interested in contraceptives can now select from a wide array of effective methods. This lecture will provide an overview of commonly-prescribed reversible contraceptive methods and current issues pertaining to their use.
Polycystic ovary syndrome (PCOS) affects as many as 10% of women. Women with PCOS have a variety of symptoms for which they see specialists, but are often not diagnosed until they present to a fertility specialist. This lecture will help primary care clinicians diagnose and treat PCOS early in the disease course to prevent worsening of symptoms and complications, including type 2 diabetes and gestational diabetes.
Dr. Johnson from the David Geffen School of Medicine at UCLA will review the significance and treatment options of Coronary Artery Disease (CAD) in women. He will discuss the differences in clinical presentation by gender, symptoms and age, along with appropriate diagnostic approaches. Appropriate treatment options and management strategies for women with CAD in accordance with the latest guidelines will also be discussed.
In this activity, Dr. Crandall will review the safety and efficacy of new selective estrogren receptor modulators (SERMs) approved for menopause hormone therapy. She will also discuss data from new studies on oral hormone replacement therapy and potential systemic effects of available vaginal estrogen medications.
Moderate to severe hot flashes affect nearly half of women during the menopause transition. At this time the risk of major depression is also heightened. Dr. Janet Pregler, Director of Iris Cantor-UCLA Women’s Health Center, will discuss the risks and benefits of using hormonal therapy as well as its alternatives to treat the symptoms of menopause in women during transition.
In this brief activity, Dr. Jane Sillman discusses some changing paradigms in the management of hot flushes and other vasomotor symptoms in menopausal women. She addresses both pharmacological and non-pharmacological strategies to manage these conditions in patients.
Using a case-based approach, the speaker will discuss the current state of menopausal hormone therapy and management strategies for patients who are not candidates for hormonal options. This talk will provide audience members with a review of recent publications that impact the management of patients’ menopausal symptoms.